Functional_Genomics_Market.JPG

Functional Genomics Market Size, Share & Trends Analysis Report by Product (Kits & Assays and Instruments), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray), Application (Transcriptomics, Epigenomics, Proteomics, And Metabolomics), And End-User, Region And Segment Forecasts, 2025-2034

Report Id: 1860 Pages: 180 Published: 08 July 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Functional Genomics Market Size is valued at USD 13.6 billion in 2024 and is predicted to reach USD  55.5 billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034.

Functional Genomics Market INFO

Key Industry Insights & Findings from the Report:

  • Government initiatives, private investments, and research funding aimed at advancing genomic research are driving the growth of the functional genomics market.
  • The cooperation and alliances of academic institutions, research organizations, biotechnology corporations, and pharmaceutical enterprises are promoting creativity and propelling the commercialization of functional genomics technologies.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • The initial investment & operational costs associated with these technologies can be prohibitive for smaller research institutions, academic labs, and biotech startups, limiting their adoption and hindering market growth. 

Understanding the roles and interconnections of the genes inside an organism's genome is the goal of the biological area known as functional genomics. In order to discover an organism's phenotype or observable traits entails researching how genes are expressed, controlled, and interact with one another and their environment.

The rising demand for gene therapy, personalized medicine, drug development, rising cancer incidence, and a notable rise in consumer genomics demand in recent years are the factors expanding the genomics market's expansion. Additionally, market participants' increased use of joint ventures and partnerships is anticipated to affect the genomics market's growth positively. The use of artificial intelligence in genomics has grown during the past few years. Artificial intelligence algorithms assess the data produced by sequencing technology, allowing for rapid and accurate identification of the genetic variants causing a particular disease.

However, research and therapeutic uses of genome technology have been complicated by the COVID-19 pandemic outbreak. But during the COVID-19 pandemic, a few specialized applications were beneficial to humanity in facilitating quick attention for developing efficient diagnostics, efficient therapies, and efforts to stop COVID-19 from spreading. 

Competitive Landscape:

Some of the functional genomics market players are:

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • (Integrated DNA Technologies, Inc.)
  • Exact Sciences Corporation
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • MRM Proteomics
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN
  • Thermo Fisher Scientific Inc. 

Market Segmentation:

The Functional genomics market is segmented on the basis of product, technology, application, and end-user. Based on product, the market is segmented into kits & assays and instruments. The technology segment includes Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and microarray. By application, the market is segmented into transcriptomics, epigenomics, proteomics, and metabolomics. The end-user segment includes academic & research institutions, biotechnology and biopharmaceutical companies, and other end users.

Based On Product, The Biotechnology And Biopharmaceutical Companies Segment Is Accounted As An Essential Contributor To The Functional Genomics Market

The biotechnology and biopharmaceutical companies’ category is expected to hold a significant share of the global Functional Genomics Market in 2024. The rising need for the use of genomes in drug discovery is to blame for this. Additionally, the market is being stimulated by the growing use of spatial genomics and transcriptomics technologies. Numerous studies are being conducted to develop innovative drugs utilizing genomics as a foundation. Firms are advancing drug development, target identification, biomarker discovery, and personalized medicine by leveraging functional genomics technology and methodologies.

The Transcriptomics Segment Witnessed Growth At A Rapid Rate

The transcriptomics segment is projected to grow rapidly in the global functional genomics market. This is due to RNA analysis being easier than protein analysis, and this subject of functional genomics is one of the oldest in the field, with a wealth of research and practical tools already developed. Companies create and market cutting-edge systems and technology for transcriptome analysis. These techniques include single-cell RNA-seq, RNA sequencing (RNA-seq), and microarray-based gene expression profiling. These systems enable the investigation of non-coding RNAs, alternative splicing processes, gene expression patterns, and RNA alterations.

The North American Functional Genomics Market Holds A Significant Revenue Share In The Region

The North America Functional Genomics Market is expected to register the highest market share in terms of revenue in the near future. Due to the impact of genetic expression on human health, genomics has become an essential component of all disease research and therapy development. New advancements in the field of genomics application have resulted from collaborative efforts.

Functional genomics in North America is a key and quickly expanding area of the genomics industry. North America, which consists of the United States and Canada, is renowned for its sophisticated academic institutions and robust biotechnology and pharmaceutical industries. Genome projects receive much money from governmental organizations, such as the Canadian Institutes of Health Research (CIHR) in Canada and the National Institutes of Health (NIH) in the US. The Asia Pacific functional genomics market is a fast-expanding and dynamic segment of the genomics industry. The Asia Pacific region, encompassing China, Japan, India, South Korea, and Australia, is seeing substantial advances in genomics research and technology.

Recent Developments:

  • In March 2023, Illumina, Inc. introduced a new cloud-based program called Connected Insights, which allows tertiary analysis of clinical next-generation sequencing data. This program will provide whole-genome sequencing for uncommon diseases, genomic profiling (CGP) for advanced tumours, and other cutting-edge uses.
  • In February 2023, Thermo Fisher Scientific, Inc. (USintroduced the TrueMark STI Select Panel, a polymerase chain reaction (PCR) test intended solely for research purposes that measure Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium.

Functional Genomics Market Report Scope:

Report Attribute

Specifications

Market size value in 2024

USD 13.6 Bn

Revenue forecast in 2034

USD 55.5 Bn

Growth rate CAGR

CAGR of 15.3% from 2025 to 2034

Quantitative units

Representation of revenue in US$ Billion, and CAGR from 2025 to 2034

Historic Year

2021 to 2024

Forecast Year

2025-2034

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Product, Technology, Application, And End-User

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia

Competitive Landscape

Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., and Danaher. (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA, MRM Proteomics, Pacific Biosciences of California, Inc., Promega Corporation, QIAGEN, Thermo Fisher Scientific Inc.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.


Deprecated: stripslashes(): Passing null to parameter #1 ($string) of type string is deprecated in /home/z8nbkwptb7pj/public_html/report-details.php on line 209

Segmentation of Functional Genomics Market-

Functional Genomics Market By Product-

  • Kits and Assays
  • Instruments 

Functional Genomics Market By Technology-

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Other

Functional Genomics Market By Application-

  • Transcriptomics
  • Epigenomics
  • Proteomics
  • Metabolomics

Functional Genomics Market By End-User-

  • Academic & Research Institutions
  • Biotechnology and Biopharmaceutical Companies
  • Other End Users

Functional Genomics Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.
Frequently Asked Questions

Artificial Intelligence (AI) In Dental Imaging Market Size is valued at USD 417.5 Mn in 2023 and is predicted to reach USD 3,833.8 Mn by the year 2031

Artificial Intelligence (AI) In Dental Imaging Market is expected to grow at an 32.5% CAGR during the forecast period for 2024-2031.

Dentsply Sirona, Inc., Planmeca Group (Planmeca Oy), Envista Holdings Corporation, Vatech Co., Ltd., Apteryx Imaging Inc. (Planet Dds Inc.), 3shape A/

Technology, Imaging Type, Application, and End User are the leading segments of the Artificial Intelligence (AI) In Dental Imaging Market.

North American region is leading the Artificial Intelligence (AI) In Dental Imaging Market

Releated Report Box